Crossref
"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy"
ARC Journal of Anesthesiology · 2016
DOI: 10.20431/2455-9792.0102001 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARC Journal of Anesthesiology, 2016.
Abstract (Originalsprache)
PeriPartum CardioMyopathy (PPCM) is a rare but potentially devastating cause of heart failure.We reported the case of a 31-year-old female who developed cardiogenic shock twelve hours post-delivery secondary to PPCM that was successfully treated with combined supportive care, including the cabergoline, levosimendan and IABP.
Zitieren
APA
(2016). "Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy". ARC Journal of Anesthesiology. https://doi.org/10.20431/2455-9792.0102001
Vancouver
"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy". ARC Journal of Anesthesiology. 2016. doi:10.20431/2455-9792.0102001
BibTeX
@article{euvimed2016,
title = {"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy"},
journal = {ARC Journal of Anesthesiology},
year = {2016},
doi = {10.20431/2455-9792.0102001}
}
EUVIMED